BIG
FLGT icon

Brooklyn Investment Group’s Fulgent Genetics FLGT Stock Holding History

Brooklyn Investment Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,093
Closed -$41.6K – 1384
2025
Q2 		$41.6K Buy
2,093
+1,721
+463% +$33.5K 0.01% 1445
2025
Q1 		$6.29K Buy
+372
New +$6.34K ﹤0.01% 1732

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Brooklyn Investment Group's FLGT Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 2,093 shares — an estimated $41.6K sold.

Brooklyn Investment Group first reported a position in FLGT in Q1 2025 and held it in 2 quarters. The position peaked at $41.6K in Q2 2025. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 2,093 Fulgent Genetics shares in Q3 2025, an estimated $41.6K.
  • Brooklyn Investment Group first reported a position in Fulgent Genetics in Q1 2025 and held it in 2 quarters.
  • Brooklyn Investment Group's Fulgent Genetics position peaked at $41.6K in Q2 2025.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.